The incidence of alterations of the maxilla and mandible at radiographic screening was evaluated in 193 patients with multiple myeloma, both at the time of diagnosis and after the start of chemotherapy during the course of the disease. Although the study confirms that osteolytic lesions are more frequent in the mandible than in the maxilla, it showed that their incidence was lower than reported in the past. Furthermore, these lesions were mostly asymptomatic and were observed in patients who had extensive skeletal involvement, particularly at the skull level. These findings indicate that systematic radiologic monitoring of the stomatognathic system should be performed, particularly in patients with multiple myeloma at an advanced stage
Plasma cell neoplasms such as multiple myeloma (MM), solitary plasmacytoma of the bone and extra med...
Multiple myeloma (MM) is a disease reported to account for 1 % of all cancers and 10 % of hematologi...
Multiple myeloma is the most common haematological malignancy accounting for 10 % of all haematologi...
Multiple myeloma is a systemic B-cell lymphoproliferative disease that causes osteolytic lesions in ...
Objective: The aim of this article is to summarize the main radiological evidences induced by multip...
Multiple myeloma is an uncommon hematologic malignancy which is characterized by monoclonal prolifer...
Multiple myeloma is a monoclonal malignant proliferation of plasma cells that causes osteolytic lesi...
Background: Jawbone involvement and destructive bone lesions in the mandible and maxilla are reporte...
Objective: To review published data on oral manifestations of multiple myeloma. Methods: An electron...
Plasma cell neoplasms (multiple myeloma, solitary plasmocytoma of bone and extra medullar plasmocyto...
Multiple myeloma is a systemic B-cell lymphoproliferative disease with varied manifestations. Its di...
Four cases of multiple myeloma presenting symptoms in the oral and maxillofacial region are reported...
Several systemic diseases initially present with various oral manifestations. Investigation of these...
The occurrence of a mandibular lesion as the first sign of multiple myeloma (MM) is uncommon. This r...
Background/purpose: Myeloma jaw lesions are not uncommon. The study aimed to investigate the status ...
Plasma cell neoplasms such as multiple myeloma (MM), solitary plasmacytoma of the bone and extra med...
Multiple myeloma (MM) is a disease reported to account for 1 % of all cancers and 10 % of hematologi...
Multiple myeloma is the most common haematological malignancy accounting for 10 % of all haematologi...
Multiple myeloma is a systemic B-cell lymphoproliferative disease that causes osteolytic lesions in ...
Objective: The aim of this article is to summarize the main radiological evidences induced by multip...
Multiple myeloma is an uncommon hematologic malignancy which is characterized by monoclonal prolifer...
Multiple myeloma is a monoclonal malignant proliferation of plasma cells that causes osteolytic lesi...
Background: Jawbone involvement and destructive bone lesions in the mandible and maxilla are reporte...
Objective: To review published data on oral manifestations of multiple myeloma. Methods: An electron...
Plasma cell neoplasms (multiple myeloma, solitary plasmocytoma of bone and extra medullar plasmocyto...
Multiple myeloma is a systemic B-cell lymphoproliferative disease with varied manifestations. Its di...
Four cases of multiple myeloma presenting symptoms in the oral and maxillofacial region are reported...
Several systemic diseases initially present with various oral manifestations. Investigation of these...
The occurrence of a mandibular lesion as the first sign of multiple myeloma (MM) is uncommon. This r...
Background/purpose: Myeloma jaw lesions are not uncommon. The study aimed to investigate the status ...
Plasma cell neoplasms such as multiple myeloma (MM), solitary plasmacytoma of the bone and extra med...
Multiple myeloma (MM) is a disease reported to account for 1 % of all cancers and 10 % of hematologi...
Multiple myeloma is the most common haematological malignancy accounting for 10 % of all haematologi...